Outlook Therapeutics
OTLK
OTLK
17 hedge funds and large institutions have $6.16M invested in Outlook Therapeutics in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
17
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$40K | |
| 2 | +$30.9K | |
| 3 | +$25K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$16K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$14K |
Top Sellers
| 1 | -$837K | |
| 2 | -$560K | |
| 3 | -$31K | |
| 4 |
Morgan Stanley
New York
|
-$7.86K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$6.16K |